Cytomid-250 Flutamide Tablet contains the active ingredient flutamide, which belongs to a class of medications known as antiandrogens. It is indicated for the treatment of prostate cancer, specifically in patients with advanced disease where surgical castration or other medical interventions are not appropriate or have failed. This works by blocking the action of androgens (male hormones), such as testosterone, on the prostate gland. Flutamide is primarily used in the treatment of prostate cancer, particularly in combination with other medications or treatments. Cytomid-250 Flutamide Tablet should be used with caution in patients with certain medical conditions, such as liver disease or glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Specification
Strength |
250 mg |
Packaging Size |
10 x 10 Tablet |
Form |
Tablet |
Prescription/Non prescription |
Prescription |
Manufacturer |
Cipla |
Composition |
Flutamide IP |
Brand |
Cytomid-250 |